Zurueck zur Suche

Reporte zur Charge U016061

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1 NJ 1 OH 1 MN 1 MI 1 IL 1

VAERS 2327117

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016061

schwer
Staat
NY
Alter
16,0
Geschlecht
M
Eingang
22.06.2022
Impfdatum
22.06.2022
Beginn
22.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Hyperhidrosis Nausea Syncope

Symptomtext

3 immunizations given in right arm, 2 immunizations given in left arm, patient had syncopal episode. Diaphoretic, and patient complained of dizziness and slight nausea; Oxygenation 98%, BP monitored q 5-10 minutes 88/60-110/60, pulse monitored q 5-10 minutes 58-60 BPM, Respirations 12-16 per minute. Patient stated he had not eaten any breakfast prior to appointment, given juice and water. Legs elevated and cold compress to neck

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None known
Vorgeschichte
-
Andere Medikamente
None known
Allergien
None known
Vorherige Impfungen
-

VAERS 2593167

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016061

mild
Staat
NJ
Alter
22,0
Geschlecht
M
Eingang
08.03.2023
Impfdatum
07.03.2023
Beginn
08.03.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

Large red swollen patch at sight of injections, L arm measuring at, R arm measuring at. Pt reported to medical and was treated with single dose of Benadryl (8 Mar 2023 @ 1200) and icing of the area. Skin marker was applied at the boarder of swelling/redness to keep track of spread.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None at this time
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA/NKA
Vorherige Impfungen
Similar adverse reaction when he recieved his first doses of MMR and Varicella which was on 7 Feb 2023.

VAERS 2006122

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016061

mild
Staat
OH
Alter
1,0
Geschlecht
F
Eingang
05.01.2022
Impfdatum
22.12.2021
Beginn
03.01.2022
Tage bis Beginn
12,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site rash Rash

Symptomtext

Rash started to appear around varicella injection sight on patient's left thigh on 01/03/2022. It then spread to her trunk, arms and neck the next day and injection sight appears bruised. Followed up with patient's mother on 01/05/2022 and mom states it looks like hives and is also on her face. Directed mom to contact their health provider and get recommendations on if she needs treatment and to see if it is break through chicken pox or a vaccine reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
unkown
Vorherige Impfungen
-

VAERS 2472399

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016061

gering
Staat
MN
Alter
-
Geschlecht
U
Eingang
08.10.2022
Impfdatum
29.09.2022
Beginn
29.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation error

Symptomtext

No additional AE reported.; VARIVAX reconstituted with normal saline instead of the supplied sterile diluent was administered to a patient.; This spontaneous report was received from a nurse and refers to a patient of an unknown age or gender. The patient's medical history, concurrent conditions, concomitant therapies and previous drugs reactions or allergies were not reported. On 29-SEP-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) at a dose of 0.5 ml, lot #U016061, expiration date reported as 01-SEP-2023 however it was verify as : 20-MAY-2023, administered as prophylaxis (strength, and route of administration were not provided) reconstituted with normal saline instead of the supplied sterile diluent (vaccine incorrect diluent used). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2275694

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016061

gering
Staat
MI
Alter
1,0
Geschlecht
M
Eingang
13.05.2022
Impfdatum
12.05.2022
Beginn
12.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered No adverse event

Symptomtext

Patient received both MMRV and Varicella.- No adverse reactions happened.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Famotidine 40mg/5mL
Allergien
None
Vorherige Impfungen
-

VAERS 2242826

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U016061

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
20.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (9.37 C) for 2 hours and 30 minutes; (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 04-APR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016061, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: 9.37 degree Celsius for 2 hours and 30 minutes; -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA004055:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-